NanoVibronix Inc. has announced a new Securities Purchase Agreement with an institutional investor, dated July 18, 2025. As part of this agreement, NanoVibronix will sell 8,889 shares of its newly-designated Series H Convertible Preferred Stock, valued at $1,000 per share, and warrants for up to 4,678,363 shares of common stock. This transaction, which closed on July 22, 2025, raised $8 million in gross proceeds. The company plans to use $5 million to redeem Series X Preferred Stock and allocate the remainder for working capital. The agreement requires stockholder approval for issuing shares beyond 19.99% of current common stock at prices below Nasdaq's minimum price rules.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。